These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9594542)

  • 1. [Repetitive instillations of cyclosporin A eyedrop induce pupillary constriction and anterior chamber inflammation-like reactions in rabbits].
    Toshida H
    Nippon Ganka Gakkai Zasshi; 1998 Apr; 102(4):256-64. PubMed ID: 9594542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Repetitive instillation of 0.1% cyclosporin A eye drops induces miosis and anterior chamber inflammation-like reactions in monkey eyes].
    Takagi S; Okisaka S; Mizukawa A; Nishikawa S
    Nippon Ganka Gakkai Zasshi; 2006 Aug; 110(8):575-80. PubMed ID: 16972648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunosuppressive effects of 0.025% cyclosporin eye drops in alpha cyclodextrin on rabbit corneal allografts].
    Takano T; Kobayashi C; Alba RM; Kanai A
    Nippon Ganka Gakkai Zasshi; 1992 Jul; 96(7):834-40. PubMed ID: 1502981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of autonomic receptor blockers on the ocular response to topical chemical irritation.
    Uusitalo H
    Acta Physiol Scand; 1984 May; 121(1):1-8. PubMed ID: 6741578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
    Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
    Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of haloperidol-induced miosis.
    Srivastava YP; Chauhan BS; Jain IP; Tripathi CD; Lal BB; Rastogi CK
    Indian J Exp Biol; 1989 Nov; 27(11):946-9. PubMed ID: 2620933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of the arachidonic acid cascade in the management of ocular inflammation.
    Srinivasan BD; Kulkarni PS
    Prog Clin Biol Res; 1989; 312():229-49. PubMed ID: 2508126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of cyclosporin for cornea graft].
    Akiyama S; Yokoyama T; Takano T; Kobayashi C; Kanai A
    Nippon Ganka Gakkai Zasshi; 1993 Mar; 97(3):378-82. PubMed ID: 8317356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
    De Campos AM; Sánchez A; Alonso MJ
    Int J Pharm; 2001 Aug; 224(1-2):159-68. PubMed ID: 11472825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclosporin A eyedrops on tear secretion in rabbit.
    Toshida H; Nakayasu K; Kanai A
    Jpn J Ophthalmol; 1998; 42(3):168-73. PubMed ID: 9690893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulations and toxicologic in vivo studies of aqueous cyclosporin A eye drops with cyclodextrin nanoparticles.
    Jóhannsdóttir S; Kristinsson JK; Fülöp Z; Ásgrímsdóttir G; Stefánsson E; Loftsson T
    Int J Pharm; 2017 Aug; 529(1-2):486-490. PubMed ID: 28720540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation.
    Di Tommaso C; Valamanesh F; Miller F; Furrer P; Rodriguez-Aller M; Behar-Cohen F; Gurny R; Möller M
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2292-9. PubMed ID: 22427552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topical antiglaucoma eye drops on prostaglandin E(2)-induced aqueous flare elevation in pigmented rabbits.
    Hayasaka Y; Hayasaka S; Zhang XY; Nagaki Y
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1142-5. PubMed ID: 11923258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
    Tan DT; Chee SP; Lim L; Lim AS
    Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin contracts the pupillary sphincter and evokes ocular inflammation through release of neuronal substance P.
    Bynke G; Håkanson R; Hörig J; Leander S
    Eur J Pharmacol; 1983 Aug; 91(4):469-75. PubMed ID: 6193973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety evaluation of nanoliposomes containing cyclosporine a after ocular administration.
    Mosallaei N; Banaee T; Farzadnia M; Abedini E; Ashraf H; Malaekeh-Nikouei B
    Curr Eye Res; 2012 Jun; 37(6):453-6. PubMed ID: 22577761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels.
    Wu Y; Yao J; Zhou J; Dahmani FZ
    Int J Nanomedicine; 2013; 8():3587-601. PubMed ID: 24092975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of pilocarpine-induced aqueous humor flare, hypotony, and miosis by topical administration of anti-inflammatory and anesthetic drugs to dogs.
    Krohne SG; Gionfriddo J; Morrison EA
    Am J Vet Res; 1998 Apr; 59(4):482-8. PubMed ID: 9563635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.
    Donnenfeld E; Perry HD; Chruscicki DA; Bitterman A; Cohn S; Solomon R
    Curr Med Res Opin; 2004 Nov; 20(11):1753-8. PubMed ID: 15537475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.